NCT07323823Not yet recruiting
The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients
The Effect of 850 nm Photobiomodulation Therapy (PBM) on the Electrical Activity of the Brain in Stroke Patients
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
The Effect of Low-Level Light Therapy on the Electrical Activity of the Brain in Stroke Patients
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- First submitted
- 22 Dec 2025
- Start date
- 31 Dec 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Pusan National University Yangsan Hospital
- Diseases
- Stroke
- NCT number
- NCT07323823
What you commit to
- Study type: Interventional
- Planned participants: 66
- From 31 Dec 2025 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with photosensitive skin at risk of developing urticaria or dermatitis.
- Patients judged to have an unstable surgical site following hemorrhagic stroke-related surgery.
- Pregnant or lactating individuals. Individuals with a history of seizures. Individuals who have participated in clinical studies twice or more in the same year or in other clinical studies within 6 months.
- Other individuals with clinically significant findings deemed medically inappropriate for the study by the principal investigator or responsible researcher.
Who the study is looking for
- Patients diagnosed with ischemic or hemorrhagic stroke by a specialist. Patients in the recovery phase within 1 year after onset; those with confirmed clinical functional impairment upon assessment, who are conscious and able to cooperate with PBM stimulation and evaluations.
- Adult patients (≥ 18 years old) ，less than 80 years old，who have signed the informed consent form, or patients with proxy consent.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.